Core Viewpoint - The medical device sector is experiencing a surge in investment, driven by improved expectations around centralized procurement and a shift towards quality control in pricing strategies [1][4][9] Group 1: Market Performance - The medical device ETF (159898) has seen a continuous inflow of funds for 9 days, with a total net inflow of 53.18 million in 10 trading days, indicating strong market interest [1][4] - Major companies like Mindray Medical and United Imaging have shown significant stock price increases, with Mindray Medical rising over 3% at the market open [1] Group 2: Policy Changes - Recent adjustments in centralized procurement rules have shifted the focus from merely lowest price bidding to ensuring cost sustainability and quality, alleviating previous pressures on the medical device sector [4][9] - The new procurement guidelines are expected to benefit high-value consumables and in-vitro diagnostics, which have been heavily impacted by past policies [4] Group 3: Industry Outlook - According to the latest data from Zhongyan Puhua Industrial Research Institute, the market size of domestic medical devices is projected to exceed 2.8 trillion by 2030, with a significant increase in market share for high-end products [4][5] - The domestic market share in high-end medical devices is expected to reach 60% by 2030, with a global market share of 15% for domestic equipment [5] Group 4: Historical Performance - The CSI All-Share Medical Device Index has shown a cumulative increase of 954% since 2005, with an annualized return exceeding 12%, outperforming other indices [7] - The medical device sector is characterized as a "long-distance runner," indicating stable demand and high technical barriers [7]